TickerFactsScreenerDevelopers

DiaMedica Therapeutics Inc. (DMAC) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2017: $1.35M2018: $16.82M2019: $3.88M2020: $7.41M2021: $4.71M2022: $4.73M2023: $4.54M2024: $3.02M2025: $15.65M$15.65M
2017Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$15.65M+417.3%
2024$3.02M-33.4%
2023$4.54M-3.9%
2022$4.73M+0.4%
2021$4.71M-36.5%
2020$7.41M+90.8%
2019$3.88M-76.9%
2018$16.82M+1143.4%
2017$1.35M—